Sort
21,453 grants matching “tuberculosis”
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$894,523Frederick Lewis Altice · Yale University · R01 · FY2019 · DA
Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research
$894,342Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2021 · OD
Structure, function, and regulation of the bacterial transcription cycle
$893,989Seth A Darst · Rockefeller University · R35 · FY2021 · GM
Promoting Adherence to TB Regimens in High-Risk Youth
$893,469San Diego State University · R01 · FY2005 · HL
A Neonatal Monkey Model of Tuberculosis Vaccination
$893,080Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI
Innovative Approaches to Tuberculosis Control
$893,064Richard E Chaisson · Johns Hopkins University · U19 · FY2008 · AI
Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis
$892,787Edward G Maliski · Oak Therapeutics, Inc. · R44 · FY2025 · AI
Collaborative Research: Microparasite-Macroparasite Interactions: Dynamics of Co-infection and Implications for Disease Control
$892,497Vanessa O Ezenwa · University Of Montana · · FY2007 · BIO
Innate Determinants of Microbial Immunity
$892,059Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
$892,054Thomas Dick · Hackensack University Medical Center · R01 · FY2024 · AI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
$891,740Neel Rajnikant Gandhi · Emory University · R01 · FY2012 · AI
A Neonatal Monkey Model for Tuberculosis Vaccination
$890,384Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$890,058Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$889,528Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2013 · DE
Technology Core
$889,513Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2017 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$889,289Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Immune Correlates of Protection from TB
$889,259Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2022 · AI
Influence of SIV replication on TB progression and immunity
$888,791Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children
$888,730Molly Forrest Franke · Harvard Medical School · U19 · FY2018 · AI
A systems approach to manipulate microbial adaptation to structured environments
$888,728Nitin S Baliga · Institute For Systems Biology · R01 · FY2021 · AI
Regulation of RANTES expression in T lymphocytes
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Function of granulysin
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Husbandry & Management Core
$888,638Gregory Brion Timmel · University Of California At Davis · U42 · FY2024 · OD
Machine Learning for Detecting Malaria and Other Infectious Diseases
$888,509Stefan Jaeger · National Library Of Medicine · ZIA · FY2019 · LM
Human T cell responses permissive for progression to active TB disease
$888,177Joel D. Ernst · Emory University · U19 · FY2020 · AI